Menchini-Fabris GF, Giorgi P, Andreini F, et al. New perspectives on the use of
Pygeum Africanum
in prostato-bladder pathology [in Italian].
Arch Ital Urol Nefrol Androl.
1988;60:313 - 322.
Carani C, Salvioli V, Scuteri A, et al. Urological and sexual evaluation of treatment of benign prostatic disease using
Pygeum africanum
at high doses [in Italian].
Arch Ital Urol Nefrol.
1991;63:341 - 345.
Bombardelli E, Morazzoni P.
Prunus africana
(Hook. f.) Kalkm.
Fitoterapia.
1997;68:205 - 218.
Bongi G. Tadenan in the treatment of prostatic adenoma. Anatomo-clinical study [in Italian].
Minerva Urol.
1972;24:129 - 139.
Rizzo M. Terapia medica dell'adenoma della prostata: Valutazione clinica comparativa tra estratto di Pygeum africanum ad alte dosi e placebo.
Farmacia Terapia.
1985;2:105 - 110.
Ranno S, Minaldi G, Viscusi G, et al. Efficacia e tollerabilita del trattamento dell'adenoma prostatico con Tadenan 50 [English abstract].
Prog Med.
1986;42:165 - 169.
Bassi P, Artibani W, De Luca V, et al. Standardized extract of
Pygeum africanum
in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo [in Italian].
Minerva Urol Nefrol.
1987;39:45 - 50.
Barlet A, Albrecht J, Aubert A, et al. Efficacy of
Pygeum africanum
extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study [translated from German].
Wien Klin Wochenschr.
1990;102:667 - 673.
Rhodes L, Primka RL, Berman C, et al. Comparison of finasteride (Proscar), a 5-alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5-alpha reductase inhibition.
Prostate.
1993;22:43 - 51.
Andro MC, Riffaud JP.
Pygeum africanum
extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 years of published experience.
Curr Ther Res.
1995;56:796 - 817.
Yablonsky F, Nicolas V, Riffaud JP, et al. Antiproliferative effect of
Pygeum africanum
extract on rat prostatic fibroblasts.
J Urol.
1997;157:2381 - 2387.
Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of
Pygeum africanum
extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension.
Urology.
1999;54:473 - 478.
Hartmann RW, Mark M, Soldati F. Inhibition of 5 alpha-reductase and aromatase by PHL-00801 (Prostatonin), a combination of PY 102
(Pygeum africanum)
and UR 102
(Urtica dioica)
extracts.
Phytomedicine.
1996;3:121 - 128.
Krzeski T, Kazon M, Borkowski A, et al. Combined extracts of
Urtica dioica
and
Pygeum africanum
in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses.
Clin Ther.
1993;15:1011 - 1020.
Bombardelli E, Morazzoni P.
Prunus africana
(Hook. f.) Kalkm.
Fitoterapia.
1997;68:205 - 218.
Wilt T, Ishani A, MacDonald R, et al.
Pygeum africanum
for benign prostatic hyperplasia.
Cochrane Database Syst Rev.
2002;(1):CD001044.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.